miércoles, 10 de junio de 2020

Early Release - Effect of Environmental Conditions on SARS-CoV-2 Stability in Human Nasal Mucus and Sputum - Volume 26, Number 9—September 2020 - Emerging Infectious Diseases journal - CDC

Early Release - Effect of Environmental Conditions on SARS-CoV-2 Stability in Human Nasal Mucus and Sputum - Volume 26, Number 9—September 2020 - Emerging Infectious Diseases journal - CDC

CDC - Centers for Disease Control and Prevention - CDC 24/7: Saving Lives. Protecting People.™

EMERGING INFECTIOUS DISEASES®

Volume 26, Number 9—September 2020
Research Letter

Effect of Environmental Conditions on SARS-CoV-2 Stability in Human Nasal Mucus and Sputum

M. Jeremiah Matson, Claude Kwe Yinda, Stephanie N. Seifert, Trenton Bushmaker, Robert J. Fischer, Neeltje van Doremalen, James O. Lloyd-Smith, and Vincent J. MunsterComments to Author 
Author affiliations: Marshall University Joan C. Edwards School of Medicine, Huntington, West Virginia, USA (M.J. Matson)Rocky Mountain Laboratories, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Hamilton, Montana, USA (M.J. Matson, C. Kwe Yinda, S.N. Seifert, T. Bushmaker, R.J. Fischer, N. van Doremalen, V.J. Munster)Montana State University, Bozeman, Montana, USA (T. Bushmaker)University of California, Los Angeles, Los Angeles, California, USA (J.O. Lloyd-Smith)

Abstract

We found that environmental conditions affect the stability of severe acute respiratory syndrome coronavirus 2 in nasal mucus and sputum. The virus is more stable at low-temperature and low-humidity conditions, whereas warmer temperature and higher humidity shortened half-life. Although infectious virus was undetectable after 48 hours, viral RNA remained detectable for 7 days.
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is shed predominantly in upper and lower airway secretions (1), and transmission likely occurs predominantly through respiratory droplets, and potentially through direct contact and fomites. We describe SARS-CoV-2 stability in human nasal mucus and sputum under different environmental conditions.
We acquired pooled human nasal mucus and sputum commercially (Lee BioSolutions Inc., https://www.leebio.comExternal Link) and mixed it with SARS-CoV-2 (SARS-CoV-2/human/USA/USA-WA1/2020) (2). We aliquoted 50 μL of each fluid containing 1 × 105 50% tissue culture infective dose/mL SARS-CoV-2 into sealed tubes (liquid setting) or onto polypropylene disks (surface setting), as previously described (3). We assessed stability under 3 environmental conditions: 4°C/40% relative humidity (RH), 21°C/40% RH, and 27°C/85% RH (RH applies only to exposed surface samples). We collected samples at specified timepoints and analyzed them for infectious virus by using endpoint titration. We extracted aliquots of collected surface samples by using the QIAGEN QIAamp Viral RNA Mini Kit (QIAGEN, https://www.qiagen.comExternal Link) and analyzed them for the presence of viral RNA by using a quantitative reverse transcription PCR assay targeting the E gene (4). We fit linear regression models to log10-transformed titer data, calculated SARS-CoV-2 half-life (t1/2) for each condition, and tested differences by using analysis of covariance. We report all experimental measurements as means of 3 replicates with SE. We considered differences with p values <0.05 statistically significant.
Thumbnail of Stability of severe acute respiratory syndrome coronavirus 2 over time in human nasal mucus and sputum under different environmental conditions: liquid nasal mucus (A), surface nasal mucus (B), liquid sputum (C), and surface sputum (D). For panels B and D, the squares correspond to viral titer on the left y-axis, and the circles correspond to viral RNA (Ct value) on the right y-axis. We collected samples in 1 mL media for each condition at 0, 1, 4, 8, and 24 hours, then daily for 7
Figure. Stability of severe acute respiratory syndrome coronavirus 2 over time in human nasal mucus and sputum under different environmental conditions: liquid nasal mucus (A), surface nasal mucus (B), liquid sputum (C),...
We observed no significant differences in SARS-CoV-2 t1/2 between environmental conditions in liquid nasal mucus. In surface nasal mucus, SARS-CoV-2 t1/2 was significantly shorter at 27°C/85% RH compared with 21°C/40% RH (p = 0.0023) and 4°C/40% RH (p = 0.0007). At 27°C/85% RH, SARS-CoV-2 t1/2 also was significantly shorter in surface compared with liquid nasal mucus (p = 0.0101). Other comparisons of nasal mucus did not demonstrate significant differences in SARS-CoV-2 t1/2 (TableFigure, panel A, B).
SARS-CoV-2 t1/2 was significantly longer in liquid sputum at 4°C than at 21°C (p = 0.0006) and 27°C (p<0.0001). In surface sputum, SARS-CoV-2 t1/2 also was significantly longer at 4°C/40% RH than at 21°C/40% RH (p = 0.0042) and 27°C/85% RH (p = 0.0002). In addition, SARS-CoV-2 t1/2 was significantly longer at 21°C/40% RH than 27°C/85% RH (p = 0.0027) in surface sputum. We observed no significant differences in SARS-CoV-2 t1/2 between liquid and surface sputum (TableFigure, panel C, D). SARS-CoV-2 RNA remained detectable for >7 days in all surface samples, with a gradual increase in cycle threshold value (decrease in detected RNA) occurring only in nasal mucus at 27°C/85% RH (Figure, panel B, D).
We previously reported on the surface stability of SARS-CoV-2 in culture media at 21°C/40% RH (3). However, SARS-CoV-2 stability is affected by its surrounding matrix and environmental conditions. The t1/2 we report here for SARS-CoV-2 in surface nasal mucus and sputum at 21°C/40% (Table) is considerably shorter than what we found in culture media under similar conditions (t1/2 6.8 [95% CI 5.6–8.2] hours) (3). In addition, we set out to determine SARS-CoV-2 stability in nasal mucus and sputum under environmental conditions that approximate temperate winter (4°C/40% RH), climate-controlled (21°C/40% RH), and temperate summer or tropical (27°C/85% RH) settings. SARS-CoV-2 was generally more stable at cooler temperatures and lower RH, and less stable at warmer temperatures and higher RH. Nevertheless, with our experimental protocol and initial titer, we predicted that SARS-CoV-2 would remain infectious in nasal mucus and sputum on surfaces for >10–12 hours even in warm, humid conditions. However, the amount of infectious SARS-CoV-2 shed and virus stability in relationship to infectious dose for humans are currently unknown, hampering conclusions regarding infectious duration and transmission. The general similarity in SARS-CoV-2 stability between liquid and surface samples suggests that in general temperature factored more heavily than humidity.
Community transmission of SARS-CoV-2 is widespread (5) and might be explained by contact with asymptomatic or presymptomatic (6) infected persons. Because of the surface stability of SARS-CoV-2, fomite transmission might also play a role. In addition, reduced surface stability of SARS-CoV-2 in human nasal mucus and sputum in warmer and more humid conditions might result in decreased virus transmission, and climatic influence on SARS-CoV-2 transmission rates might eventually drive seasonal outbreak dynamics in a postpandemic period (7), similar to other respiratory viruses (e.g., influenza A virus or human coronavirus OC43).
SARS-CoV-2 RNA has been detected on surfaces throughout clinical settings (8,9) and aboard a cruise ship for extended periods (10), but any correlation to infectious virus was previously unknown. In our study, infectious virus persisted in both nasal mucus and sputum on surfaces for ≈24 hours under climate-controlled conditions. However, viral RNA was consistently detectable for >7 days under various conditions in both nasal mucus and sputum on surfaces. These findings suggest that inferences regarding the presence of infectious virus from quantitative reverse transcription PCR data alone should be made with caution.
Mr. Matson is an MD/PhD student at the Marshall University Joan C. Edwards School of Medicine and is performing his dissertation research at the National Institute of Allergy and Infectious Diseases Virus Ecology Section. He is interested in emerging and reemerging viruses.

Acknowledgments

We thank Emmie de Wit, Brandi Williamson, and Jon Schulz for their technical assistance.
This research was supported by the Intramural Research Program of the National Institutes of Health, the National Institute of Allergy and Infectious Diseases, and the Defense Advanced Research Projects Agency’s Preventing Emerging Pathogenic Threats Program (grant no D18AC00031).

References

  1. Zhu  NZhang  DWang  WLi  XYang  BSong  Jet al.China Novel Coronavirus Investigating and Research TeamA novel coronavirus from patients with pneumonia in China, 2019. N Engl J Med2020;382:72733DOIExternal LinkPubMedExternal Link
  2. Harcourt  JTamin  ALu  XKamili  SSakthivel  SKMurray  Jet al. Severe acute respiratory syndrome coronavirus 2 from patient with coronavirus disease, United States. Emerg Infect Dis2020;26:126673DOIExternal LinkPubMedExternal Link
  3. van Doremalen  NBushmaker  TMorris  DHHolbrook  MGGamble  AWilliamson  BNet al. Aerosol and surface stability of SARS-CoV-2 as compared with SARS-CoV-1. N Engl J Med2020;382:15647DOIExternal LinkPubMedExternal Link
  4. Corman  VMLandt  OKaiser  MMolenkamp  RMeijer  AChu  DKet al. Detection of 2019 novel coronavirus (2019-nCoV) by real-time RT-PCR. Euro Surveill2020;25:25DOIExternal LinkPubMedExternal Link
  5. Liu  JLiao  XQian  SYuan  JWang  FLiu  Yet al. Community transmission of severe acute respiratory syndrome coronavirus 2, Shenzhen, China, 2020. Emerg Infect Dis2020;26:13203DOIExternal LinkPubMedExternal Link
  6. He  XLau  EHYWu  PDeng  XWang  JHao  Xet al. Temporal dynamics in viral shedding and transmissibility of COVID-19. Nat Med2020;26:6725DOIExternal LinkPubMedExternal Link
  7. Kissler  SMTedijanto  CGoldstein  EGrad  YHLipsitch  MProjecting the transmission dynamics of SARS-CoV-2 through the postpandemic period. Science2020;368:8608DOIExternal LinkPubMedExternal Link
  8. Ong  SWXTan  YKChia  PYLee  THNg  OTWong  MSYet al. Air, surface environmental, and personal protective equipment contamination by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) from a symptomatic patient. JAMA2020;323:1610DOIExternal LinkPubMedExternal Link
  9. Guo  ZDWang  ZYZhang  SFLi  XLi  LLi  Cet al. Aerosol and surface distribution of severe acute respiratory syndrome coronavirus 2 in hospital wards, Wuhan, China, 2020. Emerg Infect Dis2020;26:26DOIExternal LinkPubMedExternal Link
  10. Moriarty  LFPlucinski  MMMarston  BJKurbatova  EVKnust  BMurray  ELet al.CDC Cruise Ship Response TeamCalifornia Department of Public Health COVID-19 TeamSolano County COVID-19 TeamCalifornia Department of Public Health COVID-19 Team; Solano County COVID-19 Team. Public health responses to COVID-19 outbreaks on cruise ships—worldwide, February–March 2020. MMWR Morb Mortal Wkly Rep2020;69:34752DOIExternal LinkPubMedExternal Link
Figure
Table
Suggested citation for this article: Matson MJ, Kwe Yinda C, Seifert SN, Bushmaker T, Fischer RJ, van Doremalen N, et al. Effect of environmental conditions on SARS-CoV-2 stability in human nasal mucus and sputum Emerg Infect Dis. 2020 Sep [date cited]. https://doi.org/10.3201/eid2609.202267
DOI: 10.3201/eid2609.202267


Original Publication Date: June 08, 2020

No hay comentarios:

Publicar un comentario